Gambaran Umum
ProMIS Neurosciences, Inc., based in Canada, operates principally in the biotechnology sector, focusing on discovering and developing precision medicine therapeutics aimed at effectively treating neurodegenerative diseases, particularly Alzheimer’s disease and amyotrophic lateral sclerosis (ALS). Leveraging its proprietary discovery platform, ProMIS is adept at identifying novel therapeutic targets and generating antibodies specifically tailored to these targets. Key projects include its advanced antibody Therapeutics for Alzheimer’s disease, which focus on misfolded strains of Amyloid beta, a pivotal pathological marker of the disease. Furthermore, their extended portfolio explores potential treatments for other neurodegenerative diseases, demonstrating ProMIS Neurosciences' commitment to addressing critical unmet medical needs within the neurological disease domain.
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai operating income untuk ProMIS Neurosciences, Inc. per 2025 Jun 30 adalah -24.58 MM.
- Nilai net income untuk ProMIS Neurosciences, Inc. per 2025 Jun 30 adalah -8.43 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | -24.58 | -8.43 | |
2025-03-31 | -17.11 | -0.93 | |
2024-12-31 | -13.33 | 2.78 | |
2024-09-30 | -14.70 | -0.56 | |
2024-06-30 | -11.18 | -12.20 | |
2024-03-31 | -12.17 | -11.89 | |
2023-12-31 | -13.46 | -13.21 | |
2023-09-30 | -18.11 | -16.90 | |
2023-06-30 | -23.05 | -20.49 | |
2023-03-31 | -23.11 | -20.93 | |
2022-12-31 | -22.08 | -18.06 | |
2022-09-30 | -18.10 | -13.04 | |
2022-06-30 | -14.32 | -8.30 | |
2022-03-31 | -11.66 | -5.78 | |
2021-12-31 | -8.29 | -9.79 | |
2021-09-30 | 0.00 | -4.29 | -8.09 |
2021-06-30 | 0.00 | -3.49 | -8.15 |
2021-03-31 | 0.00 | -3.67 | -9.21 |
2020-12-31 | 0.00 | -5.66 | -5.66 |
2020-09-30 | 0.00 | -6.43 | -6.43 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | -0.03 | -0.03 |
2024-12-31 | 0.11 | 0.11 |
2024-09-30 | -0.03 | -0.02 |
2024-06-30 | -0.68 | -0.68 |
2024-03-31 | -0.79 | -0.79 |
2023-12-31 | -1.07 | -1.07 |
2023-09-30 | -1.78 | -1.78 |
2023-06-30 | -2.50 | -2.50 |
2023-03-31 | -2.67 | -2.67 |
2022-12-31 | -2.41 | |
2022-09-30 | -1.81 | -1.81 |
2022-06-30 | -1.21 | -1.21 |
2022-03-31 | -0.91 | -0.91 |
2021-12-31 | -1.69 | |
2021-09-30 | -1.54 | -1.54 |
2021-06-30 | -1.66 | -1.66 |
2021-03-31 | -1.91 | -1.91 |
2020-12-31 | -1.19 | |
2020-09-30 | -1.40 | -1.40 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk ProMIS Neurosciences, Inc. per 2025 Jun 30 adalah -24.17 MM.
- Nilai cash from investing activities untuk ProMIS Neurosciences, Inc. per 2025 Jun 30 adalah -0.00 MM.
- Nilai kas dari aktivitas pendanaan untuk ProMIS Neurosciences, Inc. per 2025 Jun 30 adalah 27.69 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | -24.17 | -0.00 | 27.69 |
2025-03-31 | -21.82 | -0.00 | 27.69 |
2024-12-31 | -27.18 | -0.00 | 27.88 |
2024-09-30 | -22.23 | -0.00 | 26.90 |
2024-06-30 | -17.93 | -0.00 | 17.94 |
2024-03-31 | -18.57 | -0.00 | 17.94 |
2023-12-31 | -10.84 | -0.00 | 17.75 |
2023-09-30 | -11.64 | 0.00 | 24.75 |
2023-06-30 | -13.90 | 0.00 | 6.49 |
2023-03-31 | -16.23 | 0.00 | 6.49 |
2022-12-31 | -17.03 | -0.00 | 6.49 |
2022-09-30 | -16.53 | 0.09 | 0.00 |
2022-06-30 | -14.92 | 0.09 | 18.64 |
2022-03-31 | -11.92 | 0.09 | 18.65 |
2021-12-31 | -9.31 | 0.09 | 25.52 |
2021-09-30 | -6.00 | -0.01 | 26.82 |
2021-06-30 | -3.64 | -0.09 | 8.20 |
2021-03-31 | -3.11 | -0.09 | 9.16 |
2020-12-31 | -4.35 | -0.11 | 3.83 |
2020-09-30 | -4.83 | -0.11 | 4.91 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- p/libro untuk ProMIS Neurosciences, Inc. pada 2025 Jun 30 adalah 1.67.
- p/tbv untuk ProMIS Neurosciences, Inc. pada 2025 Jun 30 adalah 1.67.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | 1.67 | 1.67 | |
2025-03-31 | 3.23 | 3.23 | |
2024-12-31 | 4.18 | 4.18 | |
2024-09-30 | -3.23 | -17.32 | -17.32 |
2024-06-30 | -2.44 | 376.28 | 376.28 |
2024-03-31 | 5.48 | 5.49 | |
2023-12-31 | -1.29 | 3.22 | 3.22 |
2023-09-30 | -1.79 | -4.30 | -4.29 |
2023-06-30 | -0.88 | -2.11 | -2.11 |
2023-03-31 | -1.10 | -3.72 | -3.71 |
2022-12-31 | -0.30 | 4.83 | 4.98 |
2022-09-30 | -1.63 | 26.43 | 27.24 |
2022-06-30 | -2.52 | 2.87 | 2.88 |
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
- EBIT/EV untuk ProMIS Neurosciences, Inc. pada 2025 Jun 30 adalah -0.13.
- EBIT (3 tahun) / EV untuk ProMIS Neurosciences, Inc. pada 2025 Jun 30 adalah -1.50.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | -0.13 | -1.50 |
2025-03-31 | -0.29 | -5.66 |
2024-12-31 | -0.06 | -1.20 |
2024-09-30 | -0.32 | -0.35 |
2024-06-30 | -0.45 | -0.50 |
2024-03-31 | -0.84 | -0.77 |
2023-12-31 | -3.48 | -2.63 |
2023-09-30 | -0.58 | -0.36 |
2023-06-30 | -1.22 | -0.76 |
2023-03-31 | -1.06 | -0.67 |
2022-12-31 | 29.80 | 23.34 |
2022-09-30 | -0.58 | -0.45 |
2022-06-30 | -0.50 | -0.52 |
2022-03-31 | ||
2021-12-31 | ||
2021-09-30 | ||
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 | ||
2020-09-30 |
Efektivitas Manajemen
- roa untuk ProMIS Neurosciences, Inc. pada 2025 Jun 30 adalah -0.66.
- roic untuk ProMIS Neurosciences, Inc. pada 2025 Jun 30 adalah -0.10.
- croic untuk ProMIS Neurosciences, Inc. pada 2025 Jun 30 adalah 0.62.
- ocroic untuk ProMIS Neurosciences, Inc. pada 2025 Jun 30 adalah -2.30.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -0.66 | -0.10 | 0.62 | -2.30 | |
2025-03-31 | -0.16 | -7.31 | -0.08 | 0.64 | -3.06 |
2024-12-31 | -0.04 | -0.15 | -0.08 | 0.64 | -3.06 |
2024-09-30 | -0.68 | -1.81 | |||
2024-06-30 | -2.68 | -154.19 | -10.83 | -240.90 | |
2024-03-31 | -2.44 | -2.50 | 1.92 | -1.72 | |
2023-12-31 | -3.14 | -23.15 | -2.50 | 1.92 | -1.72 |
2023-09-30 | -2.01 | -3.05 | |||
2023-06-30 | -2.01 | -3.05 | |||
2023-03-31 | -1.16 | -4.48 | |||
2022-12-31 | -0.40 | -1.23 | -16.22 | -25.00 | -21.71 |
2022-09-30 | -0.40 | -1.23 | -2.05 | -3.15 | -2.74 |
2022-06-30 | -0.98 | -0.65 | 0.26 | -1.26 | |
2022-03-31 | -0.77 | -0.75 | 0.86 | -1.55 | |
2021-12-31 | -1.58 | ||||
2021-09-30 | 0.00 | ||||
2021-06-30 | -6.59 | ||||
2021-03-31 | -7.31 | ||||
2020-12-31 | -2.73 | ||||
2020-09-30 | -8.49 |
Gross Margins
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | -2,340.17 | -2,768.83 | -3,362.27 |
2022-12-31 | -1,655.50 | -1,565.83 | -2,484.61 |
2022-09-30 | -1,655.50 | -1,565.83 | -2,484.61 |
2022-06-30 | -1,123.33 | -950.11 | -1,762.75 |
2022-03-31 | -558.63 | -466.08 | -902.62 |
2021-12-31 | -607.10 | 0.00 | -1,014.22 |
2021-09-30 | -507.90 | 0.00 | -880.63 |
2021-06-30 | -11,574.66 | -45,707.29 | -18,969.26 |
2021-03-31 | -1,534.77 | -7,348.17 | -2,864.55 |
2020-12-31 | -1,780.28 | -3,168.66 | -3,168.66 |
2020-09-30 | -1,370.58 | -2,323.67 | -2,323.67 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 1374339 |
Grupong Pang-industriya
SIC 2834 - Pharmaceutical Preparations |